{"id":"https://openalex.org/W2780972107","doi":"https://doi.org/10.1080/14656566.2017.1420165","title":"Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with type 2 diabetes mellitus","display_name":"Safety and efficacy of long-term treatment with teneligliptin: Interim analysis of a post-marketing surveillance of more than 10,000 Japanese patients with type 2 diabetes mellitus","publication_year":2017,"publication_date":"2017-12-22","ids":{"openalex":"https://openalex.org/W2780972107","doi":"https://doi.org/10.1080/14656566.2017.1420165","mag":"2780972107","pmid":"https://pubmed.ncbi.nlm.nih.gov/29268035"},"language":"en","primary_location":{"id":"doi:10.1080/14656566.2017.1420165","doi":"https://doi.org/10.1080/14656566.2017.1420165","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14656566.2017.1420165","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1420165?needAccess=true&role=button","source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1420165?needAccess=true&role=button","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5040548657","display_name":"Takashi Kadowaki","orcid":"https://orcid.org/0000-0002-5428-3582","observed_orcids":["https://orcid.org/0000-0002-5428-3582"]},"institutions":[{"id":"https://openalex.org/I74801974","display_name":"The University of Tokyo","ror":"https://ror.org/057zh3y96","country_code":"JP","type":"education","lineage":["https://openalex.org/I74801974"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Takashi Kadowaki","raw_affiliation_strings":["Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan","institution_ids":["https://openalex.org/I74801974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102876427","display_name":"Masakazu Haneda","orcid":"https://orcid.org/0000-0003-2469-2710","observed_orcids":["https://orcid.org/0000-0003-2469-2710"]},"institutions":[{"id":"https://openalex.org/I147809708","display_name":"Asahikawa Medical University","ror":"https://ror.org/025h9kw94","country_code":"JP","type":"education","lineage":["https://openalex.org/I147809708"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Masakazu Haneda","raw_affiliation_strings":["Department of Medicine, Asahikawa Medical University, Hokkaido, Japan","Medical Corporation Kyousoukai, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Asahikawa Medical University, Hokkaido, Japan","institution_ids":["https://openalex.org/I147809708"]},{"raw_affiliation_string":"Medical Corporation Kyousoukai, Osaka, Japan","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044544721","display_name":"Hiroshi Ito","orcid":"https://orcid.org/0000-0002-9857-8614","observed_orcids":["https://orcid.org/0000-0002-9857-8614","https://orcid.org/0009-0001-7587-4891"]},"institutions":[{"id":"https://openalex.org/I163770644","display_name":"Okayama University","ror":"https://ror.org/02pc6pc55","country_code":"JP","type":"education","lineage":["https://openalex.org/I163770644"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hiroshi Ito","raw_affiliation_strings":["Department of Cardiovascular Medicine, Okayama University, Okayama, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cardiovascular Medicine, Okayama University, Okayama, Japan","institution_ids":["https://openalex.org/I163770644"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050530209","display_name":"Makoto Ueno","orcid":"https://orcid.org/0000-0003-4480-0029","observed_orcids":["https://orcid.org/0000-0003-4480-0029"]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Makoto Ueno","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085600285","display_name":"Miyuki Matsukawa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Miyuki Matsukawa","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002685941","display_name":"Tomoko Yamakura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Tomoko Yamakura","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058512882","display_name":"Kazuyo Sasaki","orcid":"https://orcid.org/0000-0001-5267-8284","observed_orcids":["https://orcid.org/0000-0001-5267-8284"]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Kazuyo Sasaki","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Mayumi Kimura","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Mayumi Kimura","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Osaka, Japan","institution_ids":["https://openalex.org/I4387155982"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5080530287","display_name":"Hiroaki Iijima","orcid":"https://orcid.org/0000-0003-4621-2394","observed_orcids":["https://orcid.org/0000-0003-4621-2394"]},"institutions":[{"id":"https://openalex.org/I4387155982","display_name":"Tanabe Pharma Corporation (Japan)","ror":"https://ror.org/038ehsm73","country_code":"JP","type":"company","lineage":["https://openalex.org/I168192097","https://openalex.org/I4387155982"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Hiroaki Iijima","raw_affiliation_strings":["Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ikuyaku. Integrated Value Development Division, Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan","institution_ids":["https://openalex.org/I4387155982"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5080530287"],"corresponding_institution_ids":["https://openalex.org/I4387155982"],"apc_list":null,"apc_paid":null,"fwci":1.7445,"has_fulltext":true,"cited_by_count":13,"citation_normalized_percentile":{"value":0.8344637,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":97},"biblio":{"volume":"19","issue":"2","first_page":"83","last_page":"91"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/teneligliptin","display_name":"teneligliptin","score":1.0},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.972000002861023},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.9039999842643738},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8830000162124634},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8519999980926514},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.9509999752044678},{"id":"https://openalex.org/keywords/long-term-drug-safety","display_name":"long-term drug safety","score":0.5889999866485596},{"id":"https://openalex.org/keywords/dpp-4-inhibitors","display_name":"DPP-4 inhibitors","score":0.7699999809265137},{"id":"https://openalex.org/keywords/japanese-patients","display_name":"Japanese patients","score":0.843999981880188},{"id":"https://openalex.org/keywords/age-subgroup-analysis","display_name":"age subgroup analysis","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.933504045009613},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.720478892326355},{"id":"https://openalex.org/C61943457","wikidata":"https://www.wikidata.org/wiki/Q6046661","display_name":"Interim analysis","level":3,"score":0.6675613522529602},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.6608579754829407},{"id":"https://openalex.org/C2776957806","wikidata":"https://www.wikidata.org/wiki/Q4895105","display_name":"Interim","level":2,"score":0.6398874521255493},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.6026675701141357},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5118638873100281},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.48509228229522705},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.3493935465812683},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33158713579177856},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.33025771379470825},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3137424886226654},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.15867480635643005},{"id":"https://openalex.org/C95457728","wikidata":"https://www.wikidata.org/wiki/Q309","display_name":"History","level":0,"score":0.0},{"id":"https://openalex.org/C166957645","wikidata":"https://www.wikidata.org/wiki/Q23498","display_name":"Archaeology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003248","descriptor_name":"Constipation","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006442","descriptor_name":"Glycated Hemoglobin","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007003","descriptor_name":"Hypoglycemia","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007564","descriptor_name":"Japan","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011358","descriptor_name":"Product Surveillance, Postmarketing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011795","descriptor_name":"Surveys and Questionnaires","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D053778","descriptor_name":"Thiazolidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D053778","descriptor_name":"Thiazolidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D056486","descriptor_name":"Chemical and Drug Induced Liver Injury","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/14656566.2017.1420165","doi":"https://doi.org/10.1080/14656566.2017.1420165","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14656566.2017.1420165","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1420165?needAccess=true&role=button","source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},{"id":"pmid:29268035","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29268035","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert opinion on pharmacotherapy","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/14656566.2017.1420165","doi":"https://doi.org/10.1080/14656566.2017.1420165","is_oa":true,"landing_page_url":"https://doi.org/10.1080/14656566.2017.1420165","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/14656566.2017.1420165?needAccess=true&role=button","source":{"id":"https://openalex.org/S52020611","display_name":"Expert Opinion on Pharmacotherapy","issn_l":"1465-6566","issn":["1465-6566","1744-7666"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Expert Opinion on Pharmacotherapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320327566","display_name":"Mitsubishi Tanabe Pharma Corporation","ror":"https://ror.org/038ehsm73"},{"id":"https://openalex.org/F4320338262","display_name":"Daiichi Sankyo Europe","ror":"https://ror.org/01qhj1g70"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2780972107.pdf","grobid_xml":"https://content.openalex.org/works/W2780972107.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1420023698","https://openalex.org/W1494558589","https://openalex.org/W1972565816","https://openalex.org/W1996638018","https://openalex.org/W1998401806","https://openalex.org/W1998735190","https://openalex.org/W2006247067","https://openalex.org/W2010534563","https://openalex.org/W2019470196","https://openalex.org/W2023384663","https://openalex.org/W2026669955","https://openalex.org/W2053939314","https://openalex.org/W2064130493","https://openalex.org/W2084744936","https://openalex.org/W2091206230","https://openalex.org/W2096456867","https://openalex.org/W2098292453","https://openalex.org/W2116254891","https://openalex.org/W2124140549","https://openalex.org/W2127854619","https://openalex.org/W2133731486","https://openalex.org/W2135298024","https://openalex.org/W2142830692","https://openalex.org/W2150293876","https://openalex.org/W2171783842","https://openalex.org/W2289761273","https://openalex.org/W2338042410","https://openalex.org/W2345057135","https://openalex.org/W2559603340","https://openalex.org/W2570182724","https://openalex.org/W2588363830","https://openalex.org/W2737924655","https://openalex.org/W2744768807","https://openalex.org/W2789732774"],"related_works":["https://openalex.org/W2150293876","https://openalex.org/W2996392810","https://openalex.org/W3018397516","https://openalex.org/W2737924655","https://openalex.org/W2056182647","https://openalex.org/W2083783651","https://openalex.org/W2026669955","https://openalex.org/W2988126227","https://openalex.org/W3110548180","https://openalex.org/W2802152597"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"post-marketing":[2],"surveillance":[3],"examined":[4],"the":[5,106,110,175],"safety":[6,107,166],"and":[7,51,81,119,127,142,154,167,189],"efficacy":[8,168],"of":[9,29,77],"long-term":[10],"teneligliptin":[11,185],"therapy":[12],"in":[13,34,83,124,149,157,192,197],"Japanese":[14,193],"patients.":[15],"RESEARCH":[16],"DESIGN":[17],"AND":[18],"METHODS:":[19],"We":[20],"report":[21],"interim":[22,181],"results":[23,182],"(cut-off":[24],"date:":[25],"28":[26],"June":[27],"2017)":[28],"a":[30,155],"3-year":[31],"PMS":[32],"undertaken":[33],"subjects":[35],"with":[36,195],"type":[37],"2":[38,163],"diabetes":[39],"mellitus":[40],"(T2DM).":[41],"Survey":[42],"items":[43],"included":[44],"demographics,":[45],"treatments,":[46],"adverse":[47],"drug":[48],"reactions":[49],"(ADRs),":[50],"laboratory":[52,79],"variables.":[53],"A":[54],"subgroup":[55],"analysis":[56,108],"was":[57,114,160,186],"also":[58],"performed":[59],"across":[60],"three":[61,176],"age":[62,177],"groups":[63],"(<65":[64],"years;":[65,69],"65":[66],"to":[67],"<75":[68],"\u226575":[70],"years).":[71],"Main":[72],"outcome":[73],"measures":[74],"were":[75,103,122,136],"incidence":[76],"ADRs,":[78],"variables,":[80],"change":[82,148],"glycated":[84],"hemoglobin":[85],"(HbA1c)":[86],"from":[87,97],"baseline":[88],"over":[89],"time.":[90],"RESULTS:":[91],"Of":[92],"11,677":[93],"patients":[94,99,129,194],"registered,":[95],"data":[96],"10,532":[98],"(6,338":[100],"males/4,194":[101],"females)":[102],"analyzed":[104],"for":[105],"set;":[109],"median":[111],"administration":[112],"period":[113],"731":[115],"days.":[116],"Overall,":[117],"ADRs":[118,121,135],"serious":[120],"reported":[123],"364":[125],"(3.46%)":[126],"91":[128],"(0.86%),":[130],"respectively.":[131],"The":[132,165],"most":[133],"common":[134],"all":[137],"hypoglycemia":[138],"(0.32%),":[139],"constipation":[140],"(0.27%),":[141],"hepatic":[143],"function":[144],"abnormal":[145],"(0.24%).":[146],"No":[147],"mean":[150,158],"body":[151],"weight":[152],"occurred,":[153],"reduction":[156],"HbA1c":[159],"observed":[161],"until":[162],"years.":[164],"profiles":[169],"did":[170],"not":[171],"differ":[172],"markedly":[173],"among":[174],"groups.":[178],"CONCLUSIONS:":[179],"These":[180],"show":[183],"that":[184],"well":[187],"tolerated":[188],"improved":[190],"hyperglycemia":[191],"T2DM":[196],"clinical":[198],"practice.":[199]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-01-05T00:00:00"}